ArticleNeurology and therapy2026

Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.

Enrique Alvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.